Supreme Court flags hospital drug price markups
In short
The Supreme Court on Tuesday, September 29, raised concerns about hospital drug prices. It pointed to drugs costing 2,700 to a retailer and being billed at 27,000 to patients.
The court asked where the 10x markup was going. The report does not say what happened next or which hospital stocks were directly hit.
What the reporting says
The Supreme Court on Tuesday, September 29, flagged hospital drug markups after citing a case where drugs cost 2,700 to a retailer and were billed at 27,000 to patients. The court questioned where the 10x markup was going, according to the publisher summary. The reporting does not say what action, if any, followed or which hospital stocks were directly affected.
Why it matters
The Supreme Court’s remarks on September 29 highlighted a sharp gap between retailer cost and patient billing for drugs, according to the publisher summary. The court questioned the 10x markup in hospitals, which could draw attention to pricing practices in the healthcare sector. However, the reporting does not identify specific hospital companies, any regulatory action, or a market reaction.